<?xml version="1.0" encoding="UTF-8"?>
<p>Concerning RSV infections, intranasal administration of recombinant IFN to infants with RSV infection has shown to be safe and to decrease the duration of symptoms without affecting the time of viral shedding [
 <xref rid="B281" ref-type="bibr">281</xref>â€“
 <xref rid="B283" ref-type="bibr">283</xref>].
</p>
